期刊文献+

FRAT1、MMP-9及RhoC在喉鳞状细胞癌中的表达及临床意义 被引量:2

Expression of FRAT1, MMP-9 and RhoC in laryngeal squamous cell carcinoma and their clinical significance
原文传递
导出
摘要 目的探讨FRAT1、MMP-9及RhoC在喉鳞状细胞癌组织中的表达及其与临床病理参数的关系,同时分析三者之间的相关性。方法免疫组织化学方法检测FRAT1、RhoC及MMP-9在喉鳞癌中的表达,并结合临床病理学特征进行统计学分析。结果 FRAT1在喉癌中主要定位于细胞质,偶有核表达,散在炎症细胞也有少量表达,其阳性表达与年龄及病理分化程度有关(P<0.05)。MMP-9阳性表达与病理分化程度及淋巴结转移有关(P<0.05)。RhoC阳性表达与喉鳞癌的病理分化程度、T分期、临床分期及淋巴结转移有关(P<0.05)。FRAT1与MMP-9呈正相关(r=0.482,P=0.000),RhoC和MMP-9(r=0.429,P=0.000)呈正相关。结论 FRAT1、MMP-9及RhoC在喉癌的侵袭转移过程中可能具有重要作用。 Objective To study the expression of FRAT1,MMP-9 and RhoC in laryngeal squamous cell carcinoma(LSCC) and investigate the correlation between the expression of three indicates and clinicopathologic factors.Methods Immunohistochemistry technique was adopted to detect the expression of FRAT1,MMP-9 and RhoC in carcinoma tissues. The correlation between the expression of three indicates and clinicopathologic factors were statistically analyzed. Results The positively expressed FRAT1 was located mainly cytoplasm and it had a relationship with age and differentiation(P〈0.05). The positively expression of MMP-9 had a relationship with differentiation and node metastasis(P〈0.05). The positively expression of RhoC had a relationship with differentiation,pathologic stage,clinical stage and node metastasis(P〈0.05). Correlation analysis showed that FRAT1 and MMP-9,RhoC and MMP-9 were positive correlation with each other. Conclusion FRAT1 MMP-9 RhoC, may play important roles in the invasiveness and transfer of LSCC.
出处 《中华临床医师杂志(电子版)》 CAS 2013年第14期115-117,共3页 Chinese Journal of Clinicians(Electronic Edition)
基金 国家自然科学基金(81172584)
关键词 肿瘤 鳞状细胞 肿瘤浸润 肿瘤转移 免疫组织化学 基质金属蛋白酶类 RHO因子 FRAT1 Cancer, squamous cell Tumor invasion Tumor metastasis Immunohistochemistry Matrix metalloproteinases Rho FRAT1
  • 相关文献

参考文献16

  • 1Bilic J,Huang YL,Davidson G. Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation[J].Science,2007,(5831):1619-1622.doi:10.1126/science.1137065.
  • 2Wang Y,Liu S,Zhu H. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma[J].International Journal of Cancer,2008.561-568.
  • 3Van Amerongen R,Nawijn MC,Lambooij JP. Frat oncoproteins act at the crossroad of canonical and noncanonical Wnt-signaling pathways[J].Oncogene,2010.93-104.
  • 4Saitoh T,Mine T,Katoh M. Molecular cloning and expression of proto-oncogene FRAT1 in human cancer[J].International Journal of Oncology,2002.785-789.
  • 5Wang Y,Hewitt SM,Liu S. Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumors[J].British Journal of Cancer,2006.686-691.
  • 6Saitoh T,Katoh M. FRAT1 and FRAT2, clustered in human chromosome 10q24. 1 region, are up-regulated in gastric cancer[J].International Journal of Oncology,2001.311-315.
  • 7Guo G,Mao X,Wang P. The expression profile of FRAT1 in human gliomas[J].Brain Research,2010.152-158.
  • 8Guo G,Liu B,Zhong C. Frat1 expression and its correlation with pathologic grade,proliferation,and apoptosis in human astrocytomas[J].Medical Oncology,2011.1-6.
  • 9Shikada Y,Yoshino O,Okamoto T,m a1. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma[J].Clinical Cancer Research,2003,(14):5282-5286.
  • 10谢淑丽,朱明光,吕国悦,王广义.RhoC在肝癌细胞生长中的作用及分子机制[J].中华肿瘤杂志,2011,33(4):270-275. 被引量:5

二级参考文献28

  • 1Islam M,Lin G,Brenner JC,et al.Rho C expression and head and neck cancer metastasis.Mol Cancer Res,2009,7:1771-1780.
  • 2Kleer CG,Zhang Y,Pan Q,et al.WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer.Breast Cancer Res,2004,6:R110-115.
  • 3Johnson B,Osada T,Clay T,et al.Physiology and therapeutics of vascular endothelial growth factor in tumor immunosuppression.Curr Mol Med,2009,9:702-707.
  • 4Spangenbetg HC,Thimme R,Blum HE.Targaed therapy for hepatocellular carcinoma.Nat Rev Gastroenterol Hepatol,2009,6:423-432.
  • 5Karlsson R,Pedersen ED,Wang Z,et al.Rho GTPase function in tumorigenesis.Biochim Biophys Acta,2009,1796:91-98.
  • 6Qui(n)ones-Hinojosa A,Sanai N,Smith JS,et al.Techniques to assess the proliferative potential of brain tumors.J Neurooncol,2005,74:19-30.
  • 7Alao JP.The regulation of cyclin D1 degradation:roles in cancer development and the potential for therapeutic invention.Mol Cancer,2007,6:24.
  • 8Liggett WH,Sidransky D.Role of the p16 tumor suppressor gene in cancer.J Clin Onool,1998,16:1197-1206.
  • 9Jung P,Hermeking H.The c-MYC-AP4-p21 cascade.Cell Cycle,2009,8:982-989.
  • 10Aspenstrom P,Fransson A,Saras J. Rho GTPases have diverse effects on the organization of the actin filament system[ J]. Biochem J,2004,377:327-337

共引文献30

同被引文献71

  • 1Saitoh T,Mine T,Katoh M.Molecular cloning and expression of proto-oncogene FRAT1 in human cancer[J] .Int J Oncol,2002,20(4):785-789.
  • 2Wang Y,Hewitt SM,Liu S,et al.Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of β-catenin in ovarian tumours[J] .Br J Cancer,2006,94(5):686-691.
  • 3Guo G,Liu B,Zhong C,et al.FRAT1 expression and its correlation with pathologic grade,proliferation and apoptosis in human astrocytomas[J] .Med Oncol,2011,28 (1):1-6.
  • 4Saitoh T,Katoh M.FRAT1 and FRAT2,clustered in human chromosome 10q24.1 region,are up-regulated in gastric cancer[J] .Int J Oncol,2001,19(2):311-315.
  • 5Jonkers J,Korswagen HC,Acton D,et al.Activation of a novel proto-oncogene,FRAT1,contributes to progression of mouse T-cell lymphomas[J] .EMBO J,1997,16(3):441-450.
  • 6Yost C,Farr GH 3rd,Pierce SB,et al.GBP,an inhibitor of GSK-3,is implicated in Xenopus development and oncogenesis[J] .Cell,1998,93(6):1031-1041.
  • 7Lee YH,Heo JH,Kim TH,et al.Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors[J] .Int J Gynecol Pathol,2011,30 (3):205-217.
  • 8Van Amerongen R,Nawijn MC,Lambooij JP,et al.Frat oncoproteins act at the crossroad of canonical and noncanonical Wnt-signaling pathways[J] .Oncogene,2010,29(1):93-104.
  • 9Velasco J,Zarrabeitia MT,Prieto JR,et al.Wnt pathway genes in osteoporosis and osteoarthritis:differential expression and genetic association study[J] .Osteoporos Int,2010,21 (1):109-118.
  • 10Jonkers J,Weening JJ,van der Valk M,et al.Overexpression of Frat1 in transgenic mice leads to giomerulosclerosis and nephrotic syndrome,and provides direct evidence for the involvement of FRAT1 in lymphoma progression[J] .Oncogene,1999,18 (44):5982-5990.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部